National Policy Dialogue Adopts Landmark 10-Point Declaration Calling for Stronger Recognition of Invisible Disabilities in India

IMT News Desk
IMT News Desk
· 5 min read
National Policy Dialogue adopts a 10-point Declaration to strengthen recognition and rights of people with invisible disabilities like MS in India.

 In a significant step towards strengthening disability-inclusive healthcare and social protection in India, Members of Parliament, policymakers, neurologists, disability rights advocates, insurance stakeholders and persons living with Multiple Sclerosis (MS) today endorsed a landmark 10-point Declaration on Invisible Disabilities and Gender at the National Policy Dialogue organised on the occasion of World MS Day 2026. 

Organised by the Multiple Sclerosis Society of India (MSSI), Delhi Chapter, in association with Believe in the Invisible (BITI) and the Politics & Disability Forum at the India International Centre, New Delhi, the National Policy Dialogue was held under the theme ‘Shaping Policy. Advancing Access. Improving Lives.’ The dialogue brought together an ecosystem of stakeholders spanning government, healthcare, disability rights, insurance, academia, patient advocacy and public health to examine systemic reforms required across healthcare access, disability rights, insurance inclusion and long-term neurological care. 

The conclave featured dedicated sessions on invisible disabilities, the cost of living with MS, insurance access, digital health and policy reform. Discussions highlighted the need for earlier diagnosis, timely intervention and continuity of care, alongside more inclusive insurance frameworks and stronger financial protection mechanisms for people living with chronic neurological conditions. Participants also emphasised the importance of strengthening neurological data systems, including the Indian MS Registry Network (IMSRN), and expanding access to multidisciplinary and specialist neurological care across India.

Menaka Guruswamy, Member of Parliament, Rajya Sabha, said, “This National Policy Dialogue is an important step in deepening our understanding of Multiple Sclerosis and the realities of living with invisible disabilities. It provides a valuable platform for policymakers to learn directly from clinicians, persons living with MS, caregivers and advocates about the spectrum of challenges they navigate every day.”

Dr. R.K. Dhamija, Distinguished Neurologist, Director, IHBAS, and Chair, National Task Force, NITI Aayog Brain Health Initiative, said, “Multiple Sclerosis is a complex, unpredictable and lifelong neurological condition that requires early diagnosis, timely intervention and sustained access to advanced therapies. While often simplified for patient understanding, the clinical reality is far more challenging and demands a nuanced approach to treatment and long-term care. Investing in neurological care is not merely a healthcare expenditure; it is an economic imperative that helps prevent irreversible disability, reduces long-term care costs and enables people to remain active and productive. Improving outcomes requires a collaborative approach that brings together clinicians, policymakers, patient groups and healthcare systems to ensure timely access, continuity of care and meaningful support for people living with MS.”

Dr. Satendra Singh, Professor of Physiology, University College of Medical Sciences & GTB Hospital and Disability Rights Activist, said, “India has made significant progress in recognising a wider spectrum of disabilities through the Rights of Persons with Disabilities Act, 2016. The next step is ensuring that healthcare, disability, welfare and social protection systems work in greater alignment to translate these rights into meaningful outcomes for persons living with invisible and episodic conditions such as Multiple Sclerosis. Stronger coordination across ministries, institutions and programmes can help create a more seamless pathway to diagnosis, certification, care, support services and entitlements. Dialogues such as these are important because they bring diverse stakeholders together to identify solutions that are both inclusive and actionable.”

Renuka Malaker, Honorary National Treasurer, Multiple Sclerosis Society of India (MSSI), who is also a caregiver to a PwMS, said, “For people living with Multiple Sclerosis, the challenges often extend far beyond the disease itself. Delayed access to insurance, high out-of-pocket costs, limited awareness of available entitlements and the absence of comprehensive patient data continue to create barriers to timely care. The National Policy Dialogue has brought policymakers, clinicians, patient advocates and implementation agencies to the same table to address these gaps. We hope the Declaration catalyzes stronger insurance inclusion, better access to support systems and a more robust national understanding of the true burden of MS in India.” 

A key outcome of the conclave was the adoption of the Declaration on Invisible Disabilities and Gender, which outlines a roadmap to strengthen implementation of the Rights of Persons with Disabilities (RPwD) Act, 2016 and improve the inclusion of invisible neurological conditions within India’s healthcare, disability and welfare systems. Key recommendations include: 

  • Recognition guidelines for invisible and episodic disabilities under the RPwD Act.
  • Flexible disability certification for people with fluctuating conditions.
  • Inclusion of MS and other chronic neurological conditions within National Health Mission care pathways.
  • Expansion of the Indian MS Registry Network (IMSRN) into a broader national invisible disability registry.
  • Affordable access to disease-modifying therapies and long-term neurological care.
  • Expanded tele-neurology services across India.
  • Gender-sensitive diagnosis and treatment pathways.
  • Stronger digital monitoring of disability rights implementation.
  • Inclusive workplace policies for invisible disabilities.
  • A National Mission on Invisible Disabilities. 

In his keynote address, Dr. Dhamija highlighted that Multiple Sclerosis remains a priority focus area within the Government of India’s Brain Health Initiative. He noted that the recommendations emerging from the dialogue and the Declaration on Invisible Disabilities and Gender would contribute to ongoing national policy discussions aimed at improving accessibility, availability and affordability of care, while strengthening disability benefits, social support systems and employment opportunities for people living with chronic neurological conditions. He also underscored the importance of sustained collaboration between clinicians, patient support organisations and policymakers to translate policy intent into meaningful action and improved outcomes for persons living with MS and other invisible disabilities.

Read Next

Centre Reaffirms Commitment to Building Healthcare Infrastructure Across Northeast India; Nadda Inaugurates Super-Specialty Hospital in Meghalaya
News
June 5, 2026

Centre Reaffirms Commitment to Building Healthcare Infrastructure Across Northeast India; Nadda Inaugurates Super-Specialty Hospital in Meghalaya

Union Health Minister J P Nadda on Thursday declared that the Central Government remains firmly committed to strengthening healthcare infrastructure across the Northeast and ensuring that advanced medical services reach people living in remote and underserved areas of the region. Nadda made these remarks while inaugurating ARHI Hospital in Meghalaya’s Ri-Bhoi district- a new super-specialty […]
Article by: IMT News Desk
Hexagon Nutrition Raises Rs 41.66 Crore from Anchor Investors Ahead of Rs 139-Crore IPO Opening Today
News
June 5, 2026

Hexagon Nutrition Raises Rs 41.66 Crore from Anchor Investors Ahead of Rs 139-Crore IPO Opening Today

Mumbai-based Hexagon Nutrition Ltd has mobilised Rs 41.66 crore from anchor investors ahead of its initial public offering (IPO), which opened for public subscription on June 5 and will remain open until June 9, 2026. According to a circular uploaded on BSE’s website, the company allotted a total of 92.57 lakh equity shares to anchor […]
Article by: IMT News Desk
Otsuka’s Voyxact Shows Kidney Function Preservation in Late-Stage IgAN Trial, Setting Stage for Full FDA Approval
News
June 5, 2026

Otsuka’s Voyxact Shows Kidney Function Preservation in Late-Stage IgAN Trial, Setting Stage for Full FDA Approval

Otsuka Pharmaceutical has reported that its approved kidney disease drug Voyxact (sibeprenlimab) preserved kidney function over 12 months in a late-stage clinical study, marking a significant milestone in the treatment of immunoglobulin A nephropathy (IgAN), a serious autoimmune condition that progressively damages the kidneys. In the Phase 3 VISIONARY trial involving 320 participants, patients who […]
Article by: IMT News Desk
Akums Receives European CEP Approval for Cefpodoxime Proxetil
News
June 4, 2026

Akums Receives European CEP Approval for Cefpodoxime Proxetil

Akums Drugs & Pharmaceuticals Ltd. has received a Certificate of Suitability (CEP) from the European Directorate for the Quality of Medicines & HealthCare (EDQM) for its active pharmaceutical ingredient (API), Cefpodoxime Proxetil. The CEP certification confirms that Akums’ manufacturing process and quality standards for Cefpodoxime Proxetil comply with the requirements of the European Pharmacopoeia. The […]
Article by: IMT News Desk